Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 07, 2026
Cardlytics (CDLX): +45% Surge in 30 Days Amid Earnings Recovery and Volatility

Cardlytics (CDLX): +45% Surge in 30 Days Amid Earnings Recovery and Volatility

Key Takeaways

  • CDLX stock rose approximately +45% over the last 30 days from around $0.78 to $1.13, driven by volatility and partial recovery amid earnings reactions.
  • Over the past quarter, the stock is down about -14% from $1.31, reflecting revenue declines but improved adjusted EBITDA.
  • Key drivers include Q4 2025 earnings showing revenue drop due to Bank of America exit, offset by UK growth and cost cuts.
  • Sale of Bridg assets and analyst adjustments contributed to sentiment shifts.
  • MQUs grew 18%, but ACPU fell 35%, highlighting supply growth versus pricing pressures.

Understanding Cardlytics (CDLX) and Its Place in the Market

Cardlytics, Inc. (CDLX) runs a commerce media platform fueled by first-party purchase data from financial institutions (FIs). The company works with banks to push targeted advertising and personalized cash-back offers right through digital banking channels, connecting with nearly 215 million consumers in the U.S. and U.K. At its core, the business model taps anonymized transaction data—covering about half of U.S. card spend and a quarter in the U.K.—to help marketers boost incremental sales while improving rewards for bank customers.

In the crowded digital advertising space, Cardlytics stands out with its focus on card-linked offers (CLOs), offering deterministic purchase intelligence that sets it apart from wider platforms. From what I see, fundamentals like expanding monthly qualified users (MQUs) go a long way in explaining the stock's recent moves: revenue strains from partner exits like Bank of America have dragged on the price, but tighter cost controls and growth overseas provide some resilience. I also checked this using Tickeron’s AI Screener to gauge how CDLX stacks up against industry peers.

CDLX Stock Performance: 30-Day Gains Versus Quarterly Decline

In the last 30 days, CDLX stock gained +45%, moving from a close of about $0.78 on March 6, 2026, to $1.13 on April 2, 2026. The path was marked by volatility and an upward trend, hitting a sharp low near $0.66 in mid-March before climbing steadily into late March and early April, signaling a post-earnings rebound.

Looking at the quarter, shares dropped -14%, from $1.31 around January 6 to $1.13. This included an early slide under broader pressures, a mid-quarter bottom, and a partial bounce back, all amid high volatility tied to daily news swings.

Key Factors Behind the Recent 30-Day Rally in CDLX

The 30-day upswing largely came from market responses to the Q4 2025 earnings on March 4, which delivered adjusted EBITDA of $8.5 million—beating expectations—despite revenue of $56.1 million (-24% YoY). Investors honed in on strengths like MQUs reaching 227 million (+18% YoY), positive free cash flow, and UK revenue up 35%, which helped overshadow ACPU dropping to $0.12 (-35%).

Efforts to cut costs, such as staff reductions and cloud optimizations, helped shrink net losses and lift sentiment. Wrapping up the Bridg asset sale brought balance sheet relief. Analyst moves, including price target reductions with neutral stances, fueled choppy action, but shares recovered from March lows as undervaluation became clearer in deeper stock reviews.

What Shaped CDLX Over the Full Quarter

The quarter's downward trend mirrored ongoing revenue challenges from the Bank of America partnership ending in January, along with content limits and pricing tweaks, resulting in FY 2025 revenue of $233.3 million (-16% YoY). Billings declined 13%, adding pressure in a tough ad environment.

Macro headwinds like economic uncertainty trimmed marketer spending, while shifts toward retail media pulled ad dollars elsewhere. On the positive side, Adjusted EBITDA flipped to $10.1 million positive, with U.K. progress providing a lift. Institutional positioning was mixed, and volatility spiked around Q3/Q4 earnings. Overall, caution dominated, though late-quarter recovery hints appeared.

Exploring Trending AI Robots for Smarter Trading

In my own research process, I often turn to Tickeron’s Trending AI Robots, which highlight the platform's top-performing AI trading bots out of hundreds. These bots scan and trade thousands of tickers using strategies like trend-following, mean reversion, and momentum, across timeframes from intraday scalps to long-term holds. They’re ranked by metrics such as win rate, profit factor, and Sharpe ratio, with curation tied to recent performance and market trends—especially useful in volatile setups or sectors like tech and finance. One thing that stands out is how these tools make sophisticated trading more accessible; I’ve found them helpful for refining portfolio approaches in stocks like CDLX.

Looking Ahead: What to Watch for CDLX Investors

One area I’m watching closely is Q1 2026 results, with guidance pointing to billings of $57.5-$63.5 million (-41% to -35% YoY) and negative Adjusted EBITDA. Keep an eye on U.S. advertiser stickiness after the Bank of America exit and how Bridg sale proceeds bolster liquidity. UK growth and fresh FI deals could offset U.S. strains.

Trends in the broader ad market—consumer spending patterns and inflation's effect on budgets—will matter a lot. Data privacy regulations and competition in commerce media deserve scrutiny too. The next earnings should shed light on cost savings execution, MQU expansion, and ACPU steadiness. This is important because it will signal whether the recent rebound has legs.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: CDLX

CDLX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 06, 2026

CDLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where CDLX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CDLX's RSI Oscillator exited the oversold zone, of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 18, 2026. You may want to consider a long position or call options on CDLX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDLX advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where CDLX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CDLX entered a downward trend on August 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.578) is normal, around the industry mean (49.447). P/E Ratio (0.000) is within average values for comparable stocks, (55.918). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.541). CDLX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.056). P/S Ratio (0.125) is also within normal values, averaging (29.354).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CDLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

Notable companies

The most notable companies in this group are Trade Desk (The) (NASDAQ:TTD).

Industry description

Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.

Market Cap

The average market capitalization across the Advertising/Marketing Services Industry is 4.09B. The market cap for tickers in the group ranges from 10.35K to 102.33B. APP holds the highest valuation in this group at 102.33B. The lowest valued company is MMND at 10.35K.

High and low price notable news

The average weekly price growth across all stocks in the Advertising/Marketing Services Industry was -0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 7%. MF experienced the highest price growth at 26%, while HAO experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Advertising/Marketing Services Industry was -44%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 66
Price Growth Rating: 58
SMR Rating: 87
Profit Risk Rating: 96
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
CDLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of technology that enables online banking, mobile banking and card-linked marketing

Industry AdvertisingMarketingServices

Profile
Details
Industry
Internet Software Or Services
Address
675 Ponce de Leon Avenue, NE
Phone
+1 888 798-5802
Employees
275
Web
https://www.cardlytics.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.